Hoarding Disorder study: MagPro X100 by MagVenture
Official title Rapid Non-Invasive Brain Stimulation for Hoarding Disorder
ClinicalTrials.gov ID: NCT06712914
What this study is testing
- What it's testing
- The study aims to find out whether this type of brain stimulation can lower the severity of hoarding behaviors.
- Who it's for
- Adults who have been diagnosed with hoarding disorder.
- What's involved
- Participants will receive rapid non‑invasive brain stimulation during study visits and undergo assessments of their symptoms.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Age 18-70 years
- Primary diagnosis of hoarding disorder
- Sufficient severity of hoarding symptoms
- Willing and able to understand and complete consent and study procedures
You likely can't join if
- Psychiatric or medical conditions or medications that make participation unsafe
- Pregnant or nursing females
- Previous exposure to TMS or ECT
- History of any implanted device or psychosurgery
The study team makes the final eligibility decision.
Where it is enrolling
- Palo Alto, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Palo Alto, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.